GrafTech Reports Third Quarter 2021 Results
GrafTech International reported strong financial results for Q3 2021, achieving a net income of $120 million ($0.45 per share) with a 35% net income margin. Sales increased 33% year-over-year to $347 million. Adjusted EBITDA rose 12% to $172 million, reflecting a 50% margin. The company reduced debt by $100 million this quarter and $300 million year-to-date. With a new $150 million stock repurchase program, GrafTech aims to enhance shareholder value amidst rising graphite electrode prices, expected to increase by 7-9% in Q4.
- Net income of $120 million, or $0.45 per share, with a 35% net income margin.
- Sales volume increased by 33% year-over-year.
- Adjusted EBITDA rose to $172 million, achieving a 50% margin.
- Debt reduced by $100 million this quarter, totaling $300 million year-to-date.
- Board approved a new $150 million stock repurchase program.
- Expected cost increases in Q4 2021 and into 2022 due to global pressures.
Continued Strength in Market Conditions Supporting Improved Pricing and Profitability
Third Quarter 2021 and Other Highlights
-
Net income of
, or$120 million per share, and net income margin of$0.45 35% -
Adjusted EBITDA1 of
, for a$172 million 50% adjusted EBITDA margin2 -
Sales volume increased
33% compared to the third quarter of 2020 -
Reduced debt
and$100 million year-to-date through the third quarter$300 million -
Repurchased 4.3 million shares of stock for
$46 million -
Board approves
stock repurchase program$150 million
CEO Comments
President and Chief Executive Officer
“During the third quarter, we continued to execute on our commitment to strengthen our balance sheet, reducing our debt by
Third Quarter 2021 Financial Performance
(dollars in thousands, except per share amounts) |
|
|
For the Nine Months
|
|||||||||||||
|
|
|||||||||||||||
Q3 2021 |
Q2 2021 |
Q3 2020 |
|
2021 |
2020 |
|||||||||||
Net sales |
$ |
347,348 |
|
$ |
330,750 |
|
$ |
286,987 |
|
|
$ |
982,495 |
|
$ |
886,351 |
|
Net income |
$ |
119,886 |
|
$ |
28,165 |
|
94,234 |
|
|
246,850 |
|
309,278 |
|
|||
Earnings per share (EPS)3 |
$ |
0.45 |
|
$ |
0.11 |
|
$ |
0.35 |
|
|
$ |
0.92 |
|
$ |
1.15 |
|
Cash flow from operations |
$ |
134,256 |
|
$ |
86,330 |
|
$ |
129,009 |
|
|
343,011 |
|
$ |
416,665 |
|
|
|
|
|
|
|
|
|
||||||||||
Adjusted net income1 |
$ |
119,038 |
|
$ |
114,487 |
|
$ |
96,109 |
|
|
333,405 |
|
$ |
308,344 |
|
|
Adjusted earnings per share1, 3 |
$ |
0.45 |
|
$ |
0.43 |
|
$ |
0.36 |
|
|
1.25 |
|
$ |
1.15 |
|
|
Adjusted EBITDA1 |
$ |
172,175 |
|
$ |
159,903 |
|
$ |
153,105 |
|
|
487,123 |
|
$ |
483,408 |
|
|
Adjusted free cash flow4 |
$ |
125,145 |
|
$ |
135,907 |
|
$ |
122,676 |
|
|
$ |
369,303 |
|
$ |
385,977 |
|
Net sales for the third quarter of 2021 were
Net income in the third quarter of 2021 was
In the third quarter, cash flow from operations was
Operational and Commercial Update
Key operating metrics |
|
|
|
|
For the Nine Months
|
||||||
|
|
|
|
|
|||||||
(in thousands, except percentages) |
Q3 2021 |
Q2 2021 |
Q3 2020 |
|
2021 |
2020 |
|||||
Sales volume (MT) 6 |
43 |
|
43 |
|
33 |
|
|
123 |
|
98 |
|
Production volume (MT) 7 |
39 |
|
44 |
|
32 |
|
|
119 |
|
98 |
|
Production capacity excluding |
48 |
|
51 |
|
48 |
|
|
150 |
|
150 |
|
Capacity utilization excluding |
81 |
% |
86 |
% |
67 |
% |
|
79 |
% |
65 |
% |
Total production capacity (MT) 9, 11 |
55 |
|
58 |
|
55 |
|
|
171 |
|
171 |
|
Total capacity utilization 10, 11 |
71 |
% |
76 |
% |
58 |
% |
|
70 |
% |
57 |
% |
The non-LTA prices for graphite electrodes delivered and recognized in revenue in the third quarter increased
In the fourth quarter, we expect our non-LTA price for graphite electrodes delivered and recognized in revenue to be 7
We also expect some cost increases in the fourth quarter of 2021 and into 2022, driven by recent global cost pressures, particularly for third-party needle coke, energy, and freight.
Production volumes in the third quarter of 2021 increased
Globally, steel market capacity utilization rates continue to be strong:
|
Q3 2021 |
Q2 2021 |
Q3 2020 |
|||
Global (ex- |
74 |
% |
75 |
% |
60 |
% |
|
85 |
% |
82 |
% |
64 |
% |
The estimated shipments of graphite electrodes for 2021 have been updated from our prior estimates as follows:
|
2021 |
|
2022 |
|
2023 through 2024 |
Estimated LTA volume (in thousands of MT) |
106-110 |
|
95-105 |
|
35-45 |
Estimated LTA revenue (in millions) |
|
|
|
|
|
Capital Structure and Capital Allocation
As of
We repurchased 4.3 million shares in the third quarter for approximately
For the remainder of 2021, we continue to expect our primary use of cash to be debt repayment. Our capital expenditure range expectations are unchanged, between
Conference Call Information
In connection with this earnings release, you are invited to listen to our earnings call being held on
About
________________________
1 A non-GAAP financial measure, see below for more information and a reconciliation of EBITDA, adjusted EBITDA, adjusted net income to net income, and adjusted EPS to EPS, the most directly comparable financial measures calculated and presented in accordance with accounting principles generally accepted in |
2 Adjusted EBITDA margin is calculated as adjusted EBITDA divided by net sales (Q3 2021 adjusted EBITDA of |
3 Earnings per share represents diluted earnings per share. Adjusted earnings per share represents diluted adjusted earnings per share. |
4 A non-GAAP financial measure, see below for more information and a reconciliation of adjusted free cash flow and free cash flow to cash flow from operating activities, the most directly comparable financial measure calculated and presented in accordance with GAAP. |
5 Free cash flow conversion is calculated as free cash flow divided by adjusted EBITDA (Q3 2021 free cash flow of |
6 Sales volume reflects only graphite electrodes manufactured by |
7 Production volume reflects graphite electrodes we produced during the period. |
8 In the first quarter of 2018, our |
9 Production capacity reflects expected maximum production volume during the period under normal operating conditions, standard product mix and expected maintenance outage. Actual production may vary. |
10 Capacity utilization reflects production volume as a percentage of production capacity. |
11 Includes graphite electrode facilities in Calais, |
12 Source: |
13 Source: |
14 Includes expected termination fees from a few customers that have failed to meet certain obligations under their LTAs. |
Special note regarding forward-looking statements
This news release and related discussions may contain forward-looking statements that reflect our current views with respect to, among other things, future events and financial performance. You can identify these forward-looking statements by the use of forward-looking words such as “will,” “may,” “plan,” “estimate,” “project,” “believe,” “anticipate,” “expect,” “foresee,” “intend,” “should,” “would,” “could,” “target,” “goal,” “continue to,” “positioned to,” “are confident,” or the negative versions of those words or other comparable words. Any forward-looking statements contained in this release are based upon our historical performance and on our current plans, estimates and expectations considering information currently available to us. The inclusion of this forward-looking information should not be regarded as a representation by us that the future plans, estimates, or expectations contemplated by us will be achieved. Our expectations and targets are not predictions of actual performance and historically our performance has deviated, often significantly, from our expectations and targets. These forward-looking statements are subject to various risks and uncertainties and assumptions relating to our operations, financial results, financial condition, business, prospects, growth strategy and liquidity. Accordingly, there are or will be important factors that could cause our actual results to differ materially from those indicated in these statements. We believe that these factors include, but are not limited to: the ultimate impact that the COVID-19 pandemic has on our business, results of operations, financial condition and cash flows; the cyclical nature of our business and the selling prices of our products may lead to periods of reduced profitability and net losses in the future; the possibility that we may be unable to implement our business strategies, including our ability to secure and maintain longer-term customer contracts, in an effective manner; the risks and uncertainties associated with litigation, arbitration, and like disputes, including the current stockholder litigation and disputes related to contractual commitments; the possibility that global graphite electrode overcapacity may adversely affect graphite electrode prices; pricing for graphite electrodes has historically been cyclical and the price of graphite electrodes may decline in the future; the sensitivity of our business and operating results to economic conditions and the possibility others may not be able to fulfill their obligations to us in a timely fashion or at all; our dependence on the global steel industry generally and the electric arc furnace steel industry in particular; the competitiveness of the graphite electrode industry; our dependence on the supply of petroleum needle coke; our dependence on supplies of raw materials (in addition to petroleum needle coke) and energy; our manufacturing operations are subject to hazards; changes in, or more stringent enforcement of, health, safety and environmental regulations applicable to our manufacturing operations and facilities; the legal, compliance, economic, social and political risks associated with our substantial operations in multiple countries; the possibility that fluctuation of foreign currency exchange rates could materially harm our financial results; the possibility that our results of operations could deteriorate if our manufacturing operations were substantially disrupted for an extended period, including as a result of equipment failure, climate change, regulatory issues, natural disasters, public health crises, such as the COVID-19 pandemic, political crises or other catastrophic events; our dependence on third parties for certain construction, maintenance, engineering, transportation, warehousing and logistics services; the possibility that we are unable to recruit or retain key management and plant operating personnel or successfully negotiate with the representatives of our employees, including labor unions; the possibility that we may divest or acquire businesses, which could require significant management attention or disrupt our business; the sensitivity of goodwill on our balance sheet to changes in the market; the possibility that we are subject to information technology systems failures, cybersecurity attacks, network disruptions and breaches of data security; our dependence on protecting our intellectual property; the possibility that third parties may claim that our products or processes infringe their intellectual property rights; the possibility that significant changes in our jurisdictional earnings mix or in the tax laws of those jurisdictions could adversely affect our business; the possibility that our indebtedness could limit our financial and operating activities or that our cash flows may not be sufficient to service our indebtedness; the possibility that restrictive covenants in our financing agreements could restrict or limit our operations; the fact that borrowings under certain of our existing financing agreements subject us to interest rate risk; the possibility of a lowering or withdrawal of the ratings assigned to our debt; the possibility that disruptions in the capital and credit markets could adversely affect our results of operations, cash flows and financial condition, or those of our customers and suppliers; the possibility that concentrated ownership of our common stock may prevent minority stockholders from influencing significant corporate decisions; the possibility that we may not pay cash dividends on our common stock in the future; the fact that our stockholders have the right to engage or invest in the same or similar businesses as us; the possibility that the market price of our common stock could be negatively affected by sales of substantial amounts of our common stock in the public markets, including by
These factors should not be construed as exhaustive and should be read in connection with our other cautionary statements, including the Risk Factors sections included in our most recent Annual Report on Form 10-K and other filings with the
Non-GAAP financial measures
In addition to providing results that are determined in accordance with GAAP, we have provided certain financial measures that are not in accordance with GAAP. EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted EPS, free cash flow, adjusted free cash flow, free cash flow conversion and adjusted free cash flow conversion are non-GAAP financial measures.
We define EBITDA, a non-GAAP financial measure, as net income or loss plus interest expense, minus interest income, plus income taxes and depreciation and amortization. We define adjusted EBITDA as EBITDA plus any pension and other post-employment benefit (OPEB) plan expenses, adjustments for public offerings and related expenses, non-cash gains or losses from foreign currency remeasurement of non-operating assets and liabilities in our foreign subsidiaries where the functional currency is the
We monitor adjusted EBITDA as a supplement to our GAAP measures, and believe it is useful to present to investors, because we believe that it facilitates evaluation of our period-to-period operating performance by eliminating items that are not operational in nature, allowing comparison of our recurring core business operating results over multiple periods unaffected by differences in capital structure, capital investment cycles and fixed asset base. Adjusted EBITDA margin is also a non-GAAP financial measure used by our management and our Board of Directors as supplemental information to assess the Company’s operational performance and is calculated as adjusted EBITDA divided by net sales. In addition, we believe adjusted EBITDA, adjusted EBITDA margin and similar measures are widely used by investors, securities analysts, ratings agencies, and other parties in evaluating companies in our industry as a measure of financial performance and debt-service capabilities. We also monitor the ratio of total debt to trailing twelve month adjusted EBITDA, because we believe it is a useful and widely used way to assess our leverage.
Our use of adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are:
- adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs;
- adjusted EBITDA does not reflect our cash expenditures for capital equipment or other contractual commitments, including any capital expenditure requirements to augment or replace our capital assets;
- adjusted EBITDA does not reflect the interest expense or the cash requirements necessary to service interest or principal payments on our indebtedness;
- adjusted EBITDA does not reflect tax payments that may represent a reduction in cash available to us;
- adjusted EBITDA does not reflect expenses relating to our pension and OPEB plans;
-
adjusted EBITDA does not reflect the non-cash gains or losses from foreign currency remeasurement of non-operating assets and liabilities in our foreign subsidiaries where the functional currency is the
U.S. dollar; - adjusted EBITDA does not reflect public offerings and related expenses;
- adjusted EBITDA does not reflect related party Tax Receivable Agreement adjustments;
- adjusted EBITDA does not reflect stock-based compensation or the non-cash write-off of fixed assets;
- adjusted EBITDA does not reflect the Change in Control1 charges; and
- other companies, including companies in our industry, may calculate EBITDA, adjusted EBITDA and adjusted EBITDA margin differently, which reduces its usefulness as a comparative measure.
We define adjusted net income, a non-GAAP financial measure, as net income or loss and excluding the items used to calculate adjusted EBITDA, less the tax effect of those adjustments. We define adjusted EPS, a non-GAAP financial measure, as adjusted net income divided by the weighted average of diluted common shares outstanding during the period. We believe adjusted net income and adjusted EPS are useful to present to investors because we believe that they assist investors’ understanding of the underlying operational profitability of the Company.
Free cash flow and adjusted free cash flow, non-GAAP financial measures, are metrics used by our management and our Board of Directors to analyze cash flows generated from operations. We define free cash flow as net cash provided by operating activities less capital expenditures. We define adjusted free cash flow as free cash flow adjusted by the Change in Control charges that were triggered as a result of the ownership of our largest stockholder falling below
In evaluating EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted EPS, free cash flow, adjusted free cash flow, free cash flow conversion and adjusted free cash flow conversion, you should be aware that in the future, we will incur expenses similar to the adjustments in the reconciliation presented below, other than the Change in Control1 charges. Our presentations of EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted EPS, free cash flow, adjusted free cash flow, free cash flow conversion and adjusted free cash flow conversion should not be construed as suggesting that our future results will be unaffected by these expenses or any unusual or non-recurring items. When evaluating our performance, you should consider EBITDA, adjusted EBITDA, adjusted EBITDA margin, adjusted net income, adjusted EPS, free cash flow, adjusted free cash flow, free cash flow conversion and adjusted free cash flow conversion alongside other measures of financial performance and liquidity, including our net income (loss), EPS and cash flow from operating activities, respectively, and other GAAP measures.
|
|||||||
CONDENSED CONSOLIDATED BALANCE SHEETS |
|||||||
(Dollars in thousands) |
|||||||
Unaudited |
|||||||
|
As of
|
|
As of
|
||||
ASSETS |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash and cash equivalents |
$ |
86,656 |
|
|
$ |
145,442 |
|
Accounts and notes receivable, net of allowance for doubtful accounts of
|
183,562 |
|
|
182,647 |
|
||
Inventories |
269,709 |
|
|
265,964 |
|
||
Prepaid expenses and other current assets |
64,595 |
|
|
35,114 |
|
||
Total current assets |
604,522 |
|
|
629,167 |
|
||
Property, plant and equipment |
807,532 |
|
|
784,902 |
|
||
Less: accumulated depreciation |
308,029 |
|
|
278,685 |
|
||
Net property, plant and equipment |
499,503 |
|
|
506,217 |
|
||
Deferred income taxes |
32,944 |
|
|
32,551 |
|
||
|
171,117 |
|
|
171,117 |
|
||
Other assets |
85,060 |
|
|
93,660 |
|
||
Total assets |
$ |
1,393,146 |
|
|
$ |
1,432,712 |
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
105,177 |
|
|
$ |
70,989 |
|
Short-term debt |
128 |
|
|
131 |
|
||
Accrued income and other taxes |
54,503 |
|
|
48,720 |
|
||
Other accrued liabilities |
81,661 |
|
|
56,501 |
|
||
Related party payable - tax receivable agreement |
3,922 |
|
|
21,752 |
|
||
Total current liabilities |
245,391 |
|
|
198,093 |
|
||
|
|
|
|
||||
Long-term debt |
1,127,412 |
|
|
1,420,000 |
|
||
Other long-term obligations |
71,552 |
|
|
81,478 |
|
||
Deferred income taxes |
44,316 |
|
|
43,428 |
|
||
Related party payable - tax receivable agreement long-term |
15,176 |
|
|
19,098 |
|
||
Stockholders’ equity: |
|
|
|
||||
Preferred stock, par value |
— |
|
|
— |
|
||
Common stock, par value
shares issued and outstanding as of
as of |
2,636 |
|
|
2,672 |
|
||
Additional paid-in capital |
761,748 |
|
|
758,354 |
|
||
Accumulated other comprehensive loss |
(5,774 |
) |
|
(19,641 |
) |
||
Accumulated deficit |
(869,311 |
) |
|
(1,070,770 |
) |
||
Total stockholders’ deficit |
(110,701 |
) |
|
(329,385 |
) |
||
|
|
|
|
||||
Total liabilities and stockholders’ equity |
$ |
1,393,146 |
|
|
$ |
1,432,712 |
|
|
|||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS |
|||||||||||||||
(Dollars in thousands, except per share data) |
|||||||||||||||
Unaudited |
|||||||||||||||
|
For the Three Months
|
|
For the Nine Months
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
CONSOLIDATED STATEMENTS OF OPERATIONS |
|
|
|
|
|
|
|
||||||||
Net sales |
$ |
347,348 |
|
|
$ |
286,987 |
|
|
$ |
982,495 |
|
|
$ |
886,351 |
|
Cost of sales |
170,286 |
|
|
131,862 |
|
|
518,549 |
|
|
401,379 |
|
||||
Gross profit |
177,062 |
|
|
155,125 |
|
|
463,946 |
|
|
484,972 |
|
||||
Research and development |
983 |
|
|
650 |
|
|
2,970 |
|
|
2,072 |
|
||||
Selling and administrative expenses |
19,006 |
|
|
19,062 |
|
|
114,942 |
|
|
49,995 |
|
||||
Operating profit |
157,073 |
|
|
135,413 |
|
|
346,034 |
|
|
432,905 |
|
||||
|
|
|
|
|
|
|
|
||||||||
Other (income) expense, net |
(364 |
) |
|
694 |
|
|
(361 |
) |
|
(2,309 |
) |
||||
Related party Tax Receivable Agreement expense (benefit) |
— |
|
|
— |
|
|
47 |
|
|
(3,346 |
) |
||||
Interest expense |
16,048 |
|
|
22,474 |
|
|
54,209 |
|
|
69,026 |
|
||||
Interest income |
(417 |
) |
|
(93 |
) |
|
(653 |
) |
|
(1,582 |
) |
||||
Income before provision for income taxes |
141,806 |
|
|
112,338 |
|
|
292,792 |
|
|
371,116 |
|
||||
Provision for income taxes |
21,920 |
|
|
18,104 |
|
|
45,942 |
|
|
61,838 |
|
||||
Net income |
$ |
119,886 |
|
|
$ |
94,234 |
|
|
$ |
246,850 |
|
|
$ |
309,278 |
|
|
|
|
|
|
|
|
|
||||||||
Basic income per common share: |
|
|
|
|
|
|
|
||||||||
Net income per share |
$ |
0.45 |
|
|
$ |
0.35 |
|
|
$ |
0.92 |
|
|
$ |
1.15 |
|
Weighted average common shares outstanding |
267,106,109 |
|
|
267,265,705 |
|
|
267,327,888 |
|
|
267,908,427 |
|
||||
Diluted income per common share: |
|
|
|
|
|
|
|
||||||||
Income per share |
$ |
0.45 |
|
|
$ |
0.35 |
|
|
$ |
0.92 |
|
|
$ |
1.15 |
|
Weighted average common shares outstanding |
267,178,963 |
|
|
267,279,555 |
|
|
267,441,394 |
|
|
267,920,890 |
|
||||
|
|
|
|
|
|
|
|
|
|||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS |
|||||||||||||||
(Dollars in thousands) |
|||||||||||||||
Unaudited |
|||||||||||||||
|
For the Three Months
|
|
For the Nine Months
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Cash flow from operating activities: |
|
|
|
|
|
|
|
||||||||
Net income |
$ |
119,886 |
|
|
$ |
94,234 |
|
|
$ |
246,850 |
|
|
$ |
309,278 |
|
Adjustments to reconcile net income to cash provided by operations: |
|
|
|
|
|
|
|
||||||||
Depreciation and amortization |
15,584 |
|
|
16,241 |
|
|
48,415 |
|
|
45,074 |
|
||||
Related party Tax Receivable Agreement expense (benefit) |
— |
|
|
— |
|
|
47 |
|
|
(3,346 |
) |
||||
Deferred income tax provision |
(1,985 |
) |
|
2,247 |
|
|
(6,180 |
) |
|
16,237 |
|
||||
Stock- based compensation |
262 |
|
|
763 |
|
|
16,293 |
|
|
1,887 |
|
||||
Interest expense |
2,551 |
|
|
1,587 |
|
|
9,750 |
|
|
4,768 |
|
||||
Other charges, net |
3,430 |
|
|
1,732 |
|
|
6,784 |
|
|
448 |
|
||||
Net change in working capital* |
(3,260 |
) |
|
23,155 |
|
|
47,174 |
|
|
85,098 |
|
||||
Change in related-party Tax Receivable Agreement |
— |
|
|
— |
|
|
(21,799 |
) |
|
(27,857 |
) |
||||
Change in long-term assets and liabilities |
(2,212 |
) |
|
(10,950 |
) |
|
(4,323 |
) |
|
(14,922 |
) |
||||
Net cash provided by operating activities |
134,256 |
|
|
129,009 |
|
|
343,011 |
|
|
416,665 |
|
||||
Cash flow from investing activities: |
|
|
|
|
|
|
|
||||||||
Capital expenditures |
(14,374 |
) |
|
(6,333 |
) |
|
(40,426 |
) |
|
(30,688 |
) |
||||
Proceeds from the sale of assets |
137 |
|
|
13 |
|
|
356 |
|
|
78 |
|
||||
Net cash used in investing activities |
(14,237 |
) |
|
(6,320 |
) |
|
(40,070 |
) |
|
(30,610 |
) |
||||
Cash flow from financing activities: |
|
|
|
|
|
|
|
||||||||
Debt issuance and modification costs |
(25 |
) |
|
— |
|
|
(3,109 |
) |
|
— |
|
||||
Repurchase of common stock - non-related party |
(42,378 |
) |
|
— |
|
|
(42,378 |
) |
|
(30,099 |
) |
||||
Payment of tax withholdings related to net share settlement of equity awards |
— |
|
|
— |
|
|
(4,074 |
) |
|
(71 |
) |
||||
Principal repayments on long-term debt |
(100,000 |
) |
|
(149,186 |
) |
|
(300,000 |
) |
|
(249,214 |
) |
||||
Dividends paid to non-related party |
(2,028 |
) |
|
(948 |
) |
|
(5,446 |
) |
|
(7,553 |
) |
||||
Dividends paid to related party |
(640 |
) |
|
(1,724 |
) |
|
(2,567 |
) |
|
(20,650 |
) |
||||
Other |
(1,155 |
) |
|
— |
|
|
(3,264 |
) |
|
— |
|
||||
Net cash used in financing activities |
(146,226 |
) |
|
(151,858 |
) |
|
(360,838 |
) |
|
(307,587 |
) |
||||
Net change in cash and cash equivalents |
(26,207 |
) |
|
(29,169 |
) |
|
(57,897 |
) |
|
78,468 |
|
||||
Effect of exchange rate changes on cash and cash equivalents |
(1,268 |
) |
|
354 |
|
|
(889 |
) |
|
(562 |
) |
||||
Cash and cash equivalents at beginning of period |
114,131 |
|
|
187,656 |
|
|
145,442 |
|
|
80,935 |
|
||||
Cash and cash equivalents at end of period |
$ |
86,656 |
|
|
$ |
158,841 |
|
|
$ |
86,656 |
|
|
$ |
158,841 |
|
|
|
|
|
|
|
|
|
||||||||
* Net change in working capital due to changes in the following components: |
|
|
|
|
|
|
|||||||||
Accounts and notes receivable, net |
$ |
(12,760 |
) |
|
$ |
19,695 |
|
|
$ |
(3,455 |
) |
|
$ |
78,408 |
|
Inventories |
(15,069 |
) |
|
13,295 |
|
|
(7,246 |
) |
|
10,371 |
|
||||
Prepaid expenses and other current assets |
(5,593 |
) |
|
(695 |
) |
|
(17,664 |
) |
|
5,437 |
|
||||
Income taxes payable |
15,390 |
|
|
(9,063 |
) |
|
(2,371 |
) |
|
16,032 |
|
||||
Accounts payable and accruals |
9,000 |
|
|
(59 |
) |
|
71,748 |
|
|
(25,078 |
) |
||||
Interest payable |
5,772 |
|
|
(18 |
) |
|
6,162 |
|
|
(72 |
) |
||||
Net change in working capital |
$ |
(3,260 |
) |
|
$ |
23,155 |
|
|
$ |
47,174 |
|
|
$ |
85,098 |
|
NON-GAAP RECONCILIATION |
|||||||||||||||
(Dollars in thousands) |
|||||||||||||||
The following table reconciles our non-GAAP key financial measures to the most directly comparable GAAP measures: |
|||||||||||||||
Reconciliation to Adjusted net income |
|
|
|
||||||||||||
|
|
|
|
For the Nine Months Ended
|
|||||||||||
|
Q3 2021 |
Q2 2021 |
Q3 2020 |
2021 |
2020 |
||||||||||
|
|
|
|
|
|
||||||||||
Net income |
$ |
119,886 |
|
$ |
28,165 |
|
$ |
94,234 |
|
$ |
246,850 |
|
$ |
309,278 |
|
Adjustments, pre-tax: |
|
|
|
|
|
||||||||||
Pension and OPEB plan expenses (1) |
434 |
|
430 |
|
583 |
|
1,295 |
|
1,666 |
|
|||||
Public offerings and related expenses (2) |
— |
|
241 |
|
— |
|
663 |
|
4 |
|
|||||
Non-cash gains and losses on foreign currency remeasurement (3) |
(1,542 |
) |
2,255 |
|
798 |
|
365 |
|
(441 |
) |
|||||
Stock-based compensation (4) |
262 |
|
550 |
|
764 |
|
1,580 |
|
1,891 |
|
|||||
Non-cash fixed asset write-off (5) |
— |
|
313 |
|
— |
|
313 |
|
— |
|
|||||
Related party Tax Receivable Agreement adjustment (6) |
— |
|
— |
|
— |
|
47 |
|
(3,346 |
) |
|||||
Change in control LTIP award (7) |
— |
|
73,384 |
|
— |
|
73,384 |
|
— |
|
|||||
Change in control stock-based compensation acceleration (7) |
— |
|
14,713 |
|
— |
|
14,713 |
|
— |
|
|||||
Total non-GAAP adjustments pre-tax |
(846 |
) |
91,886 |
|
2,145 |
|
92,360 |
|
(226 |
) |
|||||
Income tax impact on non-GAAP adjustments |
2 |
|
5,564 |
|
270 |
|
5,805 |
|
708 |
|
|||||
Adjusted net income |
$ |
119,038 |
|
$ |
114,487 |
|
$ |
96,109 |
|
$ |
333,405 |
|
$ |
308,344 |
|
(1) |
Service and interest cost of our OPEB plans. Also includes a mark-to-market loss (gain) for plan assets as of December of each year. |
|
(2) |
Legal, accounting, printing and registration fees associated with public offerings and related expenses. |
|
(3) |
Non-cash gains and losses from foreign currency remeasurement of non-operating assets and liabilities of our non- |
|
(4) |
Non-cash expense for stock-based compensation grants. |
|
(5) |
Non-cash fixed asset write-off recorded for obsolete assets. |
|
(6) |
Non-cash expense adjustment for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized. |
|
(7) |
In the second quarter of 2021, we incurred Change in Control charges as a result of the ownership of our largest stockholder, Brookfield, moving below |
NON-GAAP RECONCILIATION |
|||||||||||||||
(Dollars in thousands) |
|||||||||||||||
The following table reconciles our non-GAAP key financial measures to the most directly comparable GAAP measures: |
|||||||||||||||
Reconciliation to Adjusted EPS |
|
|
|
||||||||||||
|
|
|
|
For the Nine Months Ended
|
|||||||||||
|
Q3 2021 |
Q2 2021 |
Q3 2020 |
2021 |
2020 |
||||||||||
|
|
|
|
|
|
||||||||||
EPS |
$ |
0.45 |
|
$ |
0.11 |
|
$ |
0.35 |
|
$ |
0.92 |
|
$ |
1.15 |
|
Adjustments per share: |
|
|
|
|
|
||||||||||
Pension and OPEB plan expenses (1) |
— |
|
— |
|
— |
|
— |
|
0.01 |
|
|||||
Public offerings and related expenses (2) |
— |
|
— |
|
— |
|
— |
|
— |
|
|||||
Non-cash gains and losses on foreign currency remeasurement (3) |
— |
|
0.01 |
|
0.01 |
|
— |
|
— |
|
|||||
Stock-based compensation (4) |
— |
|
— |
|
— |
|
0.02 |
|
0.01 |
|
|||||
Non-cash fixed asset write-off (5) |
— |
|
— |
|
— |
|
— |
|
— |
|
|||||
Related party Tax Receivable Agreement adjustment (6) |
— |
|
— |
|
— |
|
— |
|
(0.02 |
) |
|||||
Change in control LTIP award (7) |
— |
|
0.27 |
|
— |
|
0.27 |
|
— |
|
|||||
Change in control stock-based compensation acceleration (7) |
— |
|
0.06 |
|
— |
|
0.06 |
|
— |
|
|||||
Total non-GAAP adjustments pre-tax per share |
— |
|
0.34 |
|
0.01 |
|
0.35 |
|
— |
|
|||||
Income tax impact on non-GAAP adjustments per share |
— |
|
0.02 |
|
— |
|
0.02 |
|
— |
|
|||||
Adjusted EPS |
$ |
0.45 |
|
$ |
0.43 |
|
$ |
0.36 |
|
$ |
1.25 |
|
$ |
1.15 |
|
(1) |
Service and interest cost of our OPEB plans. Also includes a mark-to-market loss (gain) for plan assets as of December of each year. |
|
(2) |
Legal, accounting, printing and registration fees associated with public offerings and related expenses. |
|
(3) |
Non-cash gains and losses from foreign currency remeasurement of non-operating assets and liabilities of our non- |
|
(4) |
Non-cash expense for stock-based compensation grants. |
|
(5) |
Non-cash fixed asset write-off recorded for obsolete assets. |
|
(6) |
Non-cash expense adjustment for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized. |
|
(7) |
In the second quarter of 2021, we incurred Change in Control charges as a result of the ownership of our largest shareholder, Brookfield, moving below |
NON-GAAP RECONCILIATION |
|||||||||||||||
(Dollars in thousands) |
|||||||||||||||
The following table reconciles our non-GAAP key financial measures to the most directly comparable GAAP measures: |
|||||||||||||||
Reconciliation to Adjusted EBITDA |
|
|
|
||||||||||||
|
|
|
|
For the Nine Months
|
|||||||||||
|
Q3 2021 |
Q2 2021 |
Q3 2020 |
2021 |
2020 |
||||||||||
|
|
|
|
|
|
||||||||||
Net income |
$ |
119,886 |
|
$ |
28,165 |
|
$ |
94,234 |
|
$ |
246,850 |
|
$ |
309,278 |
|
Add: |
|
|
|
|
|
||||||||||
Depreciation and amortization |
15,584 |
|
16,292 |
|
16,241 |
|
48,415 |
|
45,074 |
|
|||||
Interest expense |
16,048 |
|
15,994 |
|
22,474 |
|
54,209 |
|
69,026 |
|
|||||
Interest income |
(417 |
) |
(199 |
) |
(93 |
) |
(653 |
) |
(1,582 |
) |
|||||
Income taxes |
21,920 |
|
7,765 |
|
18,104 |
|
45,942 |
|
61,838 |
|
|||||
EBITDA |
$ |
173,021 |
|
$ |
68,017 |
|
$ |
150,960 |
|
$ |
394,763 |
|
$ |
483,634 |
|
Adjustments: |
|
|
|
|
|
||||||||||
Pension and OPEB plan expenses (1) |
434 |
|
430 |
|
583 |
|
1,295 |
|
1,666 |
|
|||||
Public offerings and related expenses (2) |
— |
|
241 |
|
— |
|
663 |
|
4 |
|
|||||
Non-cash gains and losses on foreign currency remeasurement (3) |
(1,542 |
) |
2,255 |
|
798 |
|
365 |
|
(441 |
) |
|||||
Stock-based compensation (4) |
262 |
|
550 |
|
764 |
|
1,580 |
|
1,891 |
|
|||||
Non-cash fixed asset write-off (5) |
— |
|
313 |
|
— |
|
313 |
|
— |
|
|||||
Related party Tax Receivable Agreement adjustment (6) |
— |
|
— |
|
— |
|
47 |
|
(3,346 |
) |
|||||
Change in control LTIP award (7) |
— |
|
73,384 |
|
— |
|
73,384 |
|
— |
|
|||||
Change in control stock-based compensation acceleration (7) |
— |
|
14,713 |
|
— |
|
14,713 |
|
— |
|
|||||
Adjusted EBITDA |
$ |
172,175 |
|
$ |
159,903 |
|
$ |
153,105 |
|
$ |
487,123 |
|
$ |
483,408 |
|
(1) |
Service and interest cost of our OPEB plans. Also includes a mark-to-market loss (gain) for plan assets as of December of each year. |
|
(2) |
Legal, accounting, printing and registration fees associated with public offerings and related expenses. |
|
(3) |
Non-cash gains and losses from foreign currency remeasurement of non-operating assets and liabilities of our non- |
|
(4) |
Non-cash expense for stock-based compensation grants. |
|
(5) |
Non-cash fixed asset write-off recorded for obsolete assets. |
|
(6) |
Non-cash expense adjustment for future payment to our sole pre-IPO stockholder for tax assets that are expected to be utilized. |
|
(7) |
In the second quarter of 2021, we incurred Change in Control charges as a result of the ownership of our largest shareholder, Brookfield, moving below |
NON-GAAP RECONCILIATION |
|||||||||||||||
(Dollars in thousands) |
|||||||||||||||
The following table reconciles our non-GAAP key financial measures to the most directly comparable GAAP measures: |
|||||||||||||||
Reconciliation to Free Cash Flow and Adjusted Free Cash Flow |
|
|
|||||||||||||
|
|
|
|
For the Nine Months Ended
|
|||||||||||
(in thousands) |
Q3 2021 |
Q2 2021 |
Q3 2020 |
2021 |
2020 |
||||||||||
|
|
|
|
|
|
||||||||||
Net cash provided by operating activities |
$ |
134,256 |
|
$ |
86,330 |
|
$ |
129,009 |
|
$ |
343,011 |
|
$ |
416,665 |
|
Capital expenditures |
(14,374 |
) |
(11,878 |
) |
(6,333 |
) |
(40,426 |
) |
(30,688 |
) |
|||||
Free cash flow |
119,882 |
|
74,452 |
|
122,676 |
|
302,585 |
|
385,977 |
|
|||||
|
|
|
|
|
|
||||||||||
Change in control payment (1) |
5,263 |
|
61,455 |
|
— |
|
66,718 |
|
— |
|
|||||
Adjusted free cash flow |
$ |
125,145 |
|
$ |
135,907 |
|
$ |
122,676 |
|
$ |
369,303 |
|
$ |
385,977 |
(1) |
In the second quarter of 2021, we incurred pre-tax Change in Control charges of |
View source version on businesswire.com: https://www.businesswire.com/news/home/20211105005224/en/
216-676-2000
Source:
FAQ
What were GrafTech's Q3 2021 financial results?
How did GrafTech's sales volume change in Q3 2021?
What is the new stock repurchase program amount announced by GrafTech?
What is the expected change in graphite electrode prices for GrafTech in Q4 2021?